Credit Suisse »

Intellia Therapeutics shares owned by Credit Suisse

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Credit Suisse

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.1M 134k 30.49
2023-09-30 $3.8M 122k 31.62
2023-06-30 $5.1M 125k 40.78
2023-03-31 $3.8M 103k 37.27
2022-12-31 $3.2M 93k 34.89
2022-09-30 $4.6M 83k 55.93
2022-06-30 $4.3M 84k 51.77
2022-03-31 $7.2M 100k 72.64
2021-12-31 $8.4M 71k 118.23
2021-09-30 $11M 80k 134.12
2021-06-30 $17M 102k 162.00
2021-03-31 $6.5M 81k 80.26
2020-12-31 $5.6M 102k 54.28
2020-09-30 $3.8M 128k 29.41
2020-06-30 $2.3M 108k 21.00
2020-03-31 $636k 61k 10.53
2019-12-31 $596k 41k 14.66
2019-09-30 $335k 25k 13.32
2019-06-30 $428k 26k 16.33
2019-03-31 $377k 20k 18.87
2018-12-31 $362k 27k 13.60
2018-09-30 $724k 25k 28.78
2018-06-30 $967k 35k 27.37
2018-03-31 $641k 30k 21.17
2017-12-31 $498k 26k 19.24
2017-09-30 $604k 24k 25.64
2016-12-31 $163k 12k 13.16
2016-09-30 $217k 14k 15.04